Skip to main content

Karyopharm Therapeutics Inc NT 10-Q, filed Nov 13, 2026

Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Inc. filed Chapter 11 on November 2, 2026, cannot file its Form 10-Q, and Nasdaq suspended trading on November 11, 2026. Its plan cancels equity without distribution, with Ayrmid transaction expected to close in first quarter of 2027. AI summary

NT 10-Q 2026-11-13 For: 2026-09-30
View Original
Added on November 14, 2026